JP2022505525A5 - - Google Patents
Info
- Publication number
- JP2022505525A5 JP2022505525A5 JP2021521800A JP2021521800A JP2022505525A5 JP 2022505525 A5 JP2022505525 A5 JP 2022505525A5 JP 2021521800 A JP2021521800 A JP 2021521800A JP 2021521800 A JP2021521800 A JP 2021521800A JP 2022505525 A5 JP2022505525 A5 JP 2022505525A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- groups
- aryl
- ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (25)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862749730P | 2018-10-24 | 2018-10-24 | |
| US201862749725P | 2018-10-24 | 2018-10-24 | |
| US201862749712P | 2018-10-24 | 2018-10-24 | |
| US62/749,712 | 2018-10-24 | ||
| US62/749,730 | 2018-10-24 | ||
| US62/749,725 | 2018-10-24 | ||
| US201862751386P | 2018-10-26 | 2018-10-26 | |
| US201862751380P | 2018-10-26 | 2018-10-26 | |
| US201862751301P | 2018-10-26 | 2018-10-26 | |
| US62/751,386 | 2018-10-26 | ||
| US62/751,380 | 2018-10-26 | ||
| US62/751,301 | 2018-10-26 | ||
| US201962801930P | 2019-02-06 | 2019-02-06 | |
| US62/801,930 | 2019-02-06 | ||
| US201962802654P | 2019-02-07 | 2019-02-07 | |
| US201962802637P | 2019-02-07 | 2019-02-07 | |
| US62/802,637 | 2019-02-07 | ||
| US62/802,654 | 2019-02-07 | ||
| US201962812813P | 2019-03-01 | 2019-03-01 | |
| US201962812517P | 2019-03-01 | 2019-03-01 | |
| US201962812794P | 2019-03-01 | 2019-03-01 | |
| US62/812,794 | 2019-03-01 | ||
| US62/812,517 | 2019-03-01 | ||
| US62/812,813 | 2019-03-01 | ||
| PCT/US2019/057682 WO2020086732A1 (en) | 2018-10-24 | 2019-10-23 | Compounds and compositions for treating conditions associated with nlrp activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022505525A JP2022505525A (ja) | 2022-01-14 |
| JP2022505525A5 true JP2022505525A5 (cg-RX-API-DMAC7.html) | 2022-10-24 |
Family
ID=68583498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021521800A Pending JP2022505525A (ja) | 2018-10-24 | 2019-10-23 | Nlrp活性に関連する状態を治療するための化合物及び組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230011652A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3870565A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022505525A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113056451A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020086732A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA126675C2 (uk) | 2017-01-23 | 2023-01-11 | Дженентек, Інк. | Хімічні сполуки як інгібітори активності інтерлейкіну-1 |
| MX2020001776A (es) | 2017-08-15 | 2020-03-24 | Inflazome Ltd | Sulfonilureas y sulfoniltioureas como inhibidores de nlrp3. |
| TW201910317A (zh) | 2017-08-15 | 2019-03-16 | 愛爾蘭商英弗雷佐姆有限公司 | 新穎化合物 |
| WO2019034693A1 (en) | 2017-08-15 | 2019-02-21 | Inflazome Limited | SULFONYLURATES AND SULFONYLTHIOURES AS INHIBITORS OF NLRP3 |
| WO2019092171A1 (en) | 2017-11-09 | 2019-05-16 | Inflazome Limited | Novel sulfonamide carboxamide compounds |
| CN111315733A (zh) | 2017-11-09 | 2020-06-19 | 英夫拉索姆有限公司 | 新颖磺酰胺甲酰胺化合物 |
| WO2019166619A1 (en) | 2018-03-02 | 2019-09-06 | Inflazome Limited | Novel compounds |
| MX2021000660A (es) | 2018-07-20 | 2021-03-25 | Hoffmann La Roche | Compuestos de sulfonilurea como inhibidores de la actividad de interleucina 1. |
| MA53172A (fr) | 2018-07-20 | 2021-05-26 | Hoffmann La Roche | Composés de sulfonimidamide en tant qu'inhibiteurs de l'activité de l'interleukine 1 |
| SG11202101480XA (en) | 2018-08-15 | 2021-03-30 | Inflazome Ltd | Novel sulfonamideurea compounds |
| WO2021009567A1 (en) | 2019-07-17 | 2021-01-21 | Zomagen Biosciences Ltd | Nlrp3 modulators |
| AU2020312800B2 (en) * | 2019-07-17 | 2026-04-23 | Zomagen Biosciences Ltd | N-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-4,5,6,7-tetrahydrobenzofuran -2-sulfonamide derivatives and related compounds as NLPR3 modulators for the treatment of multiple sclerosis (ms) |
| BR112022014480A2 (pt) | 2020-01-22 | 2022-09-13 | Hoffmann La Roche | Compostos, composições farmacêutica, método para tratar um distúrbio em um paciente, usos de um composto e de uma composição farmacêutica e kit |
| CA3175729A1 (en) | 2020-03-16 | 2021-09-23 | Zomagen Biosciences Ltd | Nlrp3 modulators |
| CN114539256B (zh) * | 2020-11-20 | 2024-02-02 | 上海拓界生物医药科技有限公司 | 三环化合物及其医药用途 |
| CN114516878B (zh) * | 2020-11-20 | 2024-02-02 | 上海拓界生物医药科技有限公司 | 三环化合物及其医药用途 |
| CN117279903A (zh) * | 2021-02-10 | 2023-12-22 | 杭州英创医药科技有限公司 | 作为nlrp3抑制剂的化合物 |
| US11932630B2 (en) | 2021-04-16 | 2024-03-19 | Novartis Ag | Heteroaryl aminopropanol derivatives |
| CN118475558A (zh) * | 2021-12-22 | 2024-08-09 | 瑞石生物医药有限公司 | 一种磺酰脲类化合物 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4671817A (en) | 1985-04-23 | 1987-06-09 | E. I. Du Pont De Nemours And Company | Herbicidal pyrazole sulfonamides |
| US4678498A (en) | 1985-06-12 | 1987-07-07 | E. I. Du Pont De Nemours And Company | Herbicidal sulfonamides |
| US5017212A (en) | 1986-03-20 | 1991-05-21 | Takeda Chemical Industries, Ltd. | Sulfonylurea compounds and herbicidal use |
| US4927453A (en) | 1986-10-17 | 1990-05-22 | E. I. Du Pont De Nemours And Company | Herbicidal sulfonamides |
| EP0318620A1 (en) | 1987-12-04 | 1989-06-07 | E.I. Du Pont De Nemours And Company | Herbicidal sulfonamides |
| AU7165591A (en) | 1990-01-22 | 1991-08-05 | E.I. Du Pont De Nemours And Company | Herbicidal sulfonylureas |
| US5169860A (en) * | 1992-03-13 | 1992-12-08 | Eli Lilly And Company | Antitumor compositions and methods of treatment |
| DK1270565T3 (da) * | 1997-01-29 | 2004-10-04 | Pfizer | 4-substitueret furan-2-sulfonamid og dets anvendelse i fremstillingen af sulfonylurinstofderivater |
| BR0014003A (pt) * | 1999-09-14 | 2002-05-21 | Pfizer Prod Inc | Tratamento de combinação com compostos de diaril sufonil uréia e il-1ra |
| US20030189215A1 (en) | 2002-04-09 | 2003-10-09 | Jong-Lam Lee | Method of fabricating vertical structure leds |
| WO2006085815A1 (en) * | 2005-02-11 | 2006-08-17 | Astrazeneca Ab | Thiazole derivatives, their process for their preparation and their use in therapy |
| DK200600313A (da) | 2006-03-03 | 2006-03-13 | Novo Nordisk As | Treating type 2 diabetes or metabolic syndrome with an interleukin 1beta inhibitor or an interleukin 1beta synthesis or release inhibitor |
| US7973051B2 (en) * | 2007-11-30 | 2011-07-05 | Hoffman-La Roche Inc. | Aminothiazoles as FBPase inhibitors for diabetes |
| JP6929792B2 (ja) * | 2015-02-16 | 2021-09-01 | ザ ユニバーシティ オブ クィーンズランド | スルホニル尿素及び関連化合物並びにその使用 |
| MA44729A (fr) * | 2016-04-18 | 2021-05-12 | Novartis Ag | Composés et compositions pour traiter des états associés à une activité de nlrp |
| EP3272739A1 (en) * | 2016-07-20 | 2018-01-24 | NodThera Limited | Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| UA126675C2 (uk) * | 2017-01-23 | 2023-01-11 | Дженентек, Інк. | Хімічні сполуки як інгібітори активності інтерлейкіну-1 |
| EP3649112A1 (en) | 2017-07-07 | 2020-05-13 | Inflazome Limited | Sulfonylureas and sulfonylthioureas as nlrp3 inhibitors |
| WO2019034693A1 (en) | 2017-08-15 | 2019-02-21 | Inflazome Limited | SULFONYLURATES AND SULFONYLTHIOURES AS INHIBITORS OF NLRP3 |
| WO2019034697A1 (en) | 2017-08-15 | 2019-02-21 | Inflazome Limited | NOVEL CARBOXAMIDE SULFONAMIDE COMPOUNDS |
| TW201910317A (zh) | 2017-08-15 | 2019-03-16 | 愛爾蘭商英弗雷佐姆有限公司 | 新穎化合物 |
| MX2020001776A (es) | 2017-08-15 | 2020-03-24 | Inflazome Ltd | Sulfonilureas y sulfoniltioureas como inhibidores de nlrp3. |
| EP3668862A1 (en) | 2017-08-15 | 2020-06-24 | Inflazome Limited | Novel sulfonamide carboxamide compounds |
| AU2018317800A1 (en) | 2017-08-15 | 2020-02-13 | Inflazome Limited | Novel sulfonamide carboxamide compounds |
| TW201910314A (zh) | 2017-08-15 | 2019-03-16 | 愛爾蘭商英弗雷佐姆有限公司 | 新穎化合物 |
-
2019
- 2019-10-23 US US17/287,834 patent/US20230011652A1/en not_active Abandoned
- 2019-10-23 WO PCT/US2019/057682 patent/WO2020086732A1/en not_active Ceased
- 2019-10-23 EP EP19805434.8A patent/EP3870565A1/en not_active Withdrawn
- 2019-10-23 JP JP2021521800A patent/JP2022505525A/ja active Pending
- 2019-10-23 CN CN201980074404.6A patent/CN113056451A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022507065A5 (cg-RX-API-DMAC7.html) | ||
| JP2020528889A5 (cg-RX-API-DMAC7.html) | ||
| JP2022507506A5 (cg-RX-API-DMAC7.html) | ||
| JP2020537657A5 (cg-RX-API-DMAC7.html) | ||
| JP2022506898A5 (cg-RX-API-DMAC7.html) | ||
| JP2019519598A5 (cg-RX-API-DMAC7.html) | ||
| JP2019515952A5 (cg-RX-API-DMAC7.html) | ||
| EP1838320B1 (en) | Cxcr4 antagonists for the treatment of medical disorders | |
| JP2019518071A5 (cg-RX-API-DMAC7.html) | ||
| TW570917B (en) | Trisubstituted 1,3,5-triazine derivatives | |
| JP6608918B2 (ja) | P38キナーゼ阻害剤としてのジアリール尿素誘導体 | |
| CN113264921B (zh) | 作为激酶抑制剂的吡唑基-脲 | |
| JP2022507505A5 (cg-RX-API-DMAC7.html) | ||
| JP2024512154A5 (cg-RX-API-DMAC7.html) | ||
| JP6464384B2 (ja) | キナーゼ阻害剤 | |
| HRP20251344T1 (hr) | SPOJEVI I PRIPRAVCI ZA LIJEČENJE STANJA POVEZANIH S AKTIVNOŠĆU NLRP-a | |
| JP2022531609A (ja) | 新規メチルキナゾリノン誘導体 | |
| RU2008141368A (ru) | Новые гетероциклические соединения замещенного пиридина с антагонистической активностью схсr3 | |
| US20160002174A1 (en) | CXCR4 Antagonists for the Treatment of Medical Disorders | |
| US20080227799A1 (en) | CXCR4 Antagonists Including Heteroatoms for the Treatment of Medical Disorders | |
| JP2021530536A (ja) | インターロイキン−1活性の阻害剤としてのスルホニル尿素化合物 | |
| JP2010540508A5 (cg-RX-API-DMAC7.html) | ||
| US20090099194A1 (en) | CXCR4 Antagonists Including Diazine And Triazine Structures For The Treatment Of Medical Disorders | |
| JP2014503574A5 (cg-RX-API-DMAC7.html) | ||
| RU2011121567A (ru) | Изоиндолиновые соединения для применения при лечении рака |